services for older adults will lead to better clinical outcomes, along with reduced service use and cost (Beswick et al. 2008; Boult and Wieland 2010; Milani and Lavie 2015) . However, evidence for this remains scarce (Eklund and Wilhelmson 2009; Low, Yap, and Brodaty 2011; World Health Organization 2015a) . Moreover, most of the studies on integrated care services focus on older adults already in need of care (Eng et al. 1997; Hebert et al. 2003; Boyd et al. 2007) , without taking into account that the health status of older adults may suddenly change and take a turn for the worse (Boult and Wieland 2010) . Opportunities for proactive and preventive care and support to postpone a decline in health are therefore not exploited (Fries 1980; Stuck et al. 1999) .
We developed Embrace (in Dutch "SamenOud") (Spoorenberg et al. 2013) as an integrated care service for all older adults living in the community. Embrace combines the Chronic Care Model (CCM) (Wagner et al. 2001 )-a well-known generic framework for improvements in health care-with a Population Health Management model (PHM), the Kaiser Permanente Triangle (Singh and Ham 2006) . One of the main goals of Embrace is to improve the health outcomes of older adults and to modify the factors that may influence these health outcomes (Kindig 2007) . Embrace uses the self-reported levels of "case complexity" (Peters et al. 2013 ) and "frailty" (Peters et al. 2012 ) in order to stratify older adults into nondisease and nonservice-specific risk profiles (Lynn et al. 2007; Lafortune et al. 2009) , with the intensity of care and support offered depending on the risk profile.
Whether integrated primary care services for older adults, as Embrace is, fulfill its aims are still undecided (Spoorenberg et al. 2015b (Spoorenberg et al. , 2018 Uittenbroek et al. 2017) , and endpoints such as quality-adjusted life years and computerized balanced allocation procedure was performed to achieve equal distributions between the intervention (Embrace) and control groups for those characteristics that potentially affect intervention outcomes. The balancing criteria were age, sex, complexity of care needs, frailty, living situation, number of chronic conditions, whether or not receiving home care, and whether or not receiving help with filling out the questionnaires.
Due to the nature of the study, Elderly Care Team members knew which participants were assigned to Embrace; however, members of the Elderly Care Teams did not know the risk profiles of the participants in the control group. The participants were informed in writing as to whether they were assigned to an intervention or a control group. The data manager was not blinded; researchers were blinded until the analyses started.
Intervention
Within Embrace, a GP-led Elderly Care Team was assembled for each participating GP-practice, which also consisted of an elderly care physician (also known as a nursing home physician), a community nurse (case manager for older adults with risk profile "Complex care needs"), and a social worker (case manager for older adults with risk profile "Frail"). The Elderly Care Team provided older adults with comprehensive, person-centered, proactive, and preventive care and support. Participants within the profiles "Frail" and "Complex care needs" received individual care and support from a case manager, who visited the older adults at home and focused on the older adults' selfdefined problems such as mobility of joint functions, emotional well-being, and exercise tolerance (Spoorenberg et al. 2015a) . Older adults within the profile "Robust" were monitored by the Elderly Care Team, which reviewed their medical files and medications at least once a year. All participating older adults were offered a self-management support and prevention program that emphasized preventive measures and endorsed a healthy lifestyle, while maintaining self-management abilities. See Supplementary Table S1 for more details.
Care-as-usual
The control group received care-as-usual as provided by their GP, and local health care and social care organizations. Patients enter the health care system via primary health care, in which the GP also acts as a gatekeeper for specialized (secondary) medical care. The mean number of GP visits in the Netherlands increases with age from four visits per year at age 45-64 to 10 visits per year for people aged 75 years and older (Statistics Netherlands 2013).
Resource Use and Valuation
Data on costs of Dutch health care and social care for all older adults were obtained from the three sources of reimbursement, based on Dutch health care and social care legislation (Schafer et al. 2010) . These data come closest to reality, as these are actually reimbursed costs. However, copayments or out-of-pocket costs are not included (e.g., a compulsory copayment for curative care of 220 EUR per person per year). Costs of medical (curative) care-for example, primary care, hospital care, medications, or paramedical care-are covered by the Health Insurance Act and are reimbursed by various competing health insurers. In the Netherlands, this insurance is compulsory for all Dutch residents. In this study, we obtained data from two of the major health care insurers active throughout the Netherlands (Menzis and Zilveren Kruis), covering 77 percent of the study population. Missing data on medical (curative) care costs for the remaining 23 percent were handled as missing data and imputed by multiple imputation (see also statistical analysis paragraph). Long-term care-for example, institutional care and home care-for all older adults is covered by the Chronic Care Act, tax funded with additional patient copayment and reimbursed by the dominant health insurer's long-term care administration office (Menzis). We were able to obtain data on all participating older adults for this. Finally, social care-for example, home help and home adjustment-is covered by the Social Support Act, tax funded with additional patient copayment, and reimbursed by the municipalities, and we obtained data from three municipalities, covering all participating older adults. Informal care was assessed using self-report questionnaire, the minimal dataset-economic evaluation (MDS-e), older adults filled out as well. Hours of care provided (per week) were multiplied by cost prices, according to Dutch guidelines for economic evaluations (EUR 13.27 per hour) (Hakkaart-van Roijen, Tan, and Bouwmans 2011) and converted to annual costs. Intervention costs were available on an individual basis, from the records of funding, as granted by the Dutch Healthcare Authority and reimbursed by the long-term care administration office (see Table S1 ). The total sum of care and support expenditures was calculated for the year prior to the intervention (baseline) and for the year after the start of the intervention. Data on costs that could not be retrieved were treated as missing values. All costs are presented in Euros (EUR) for the intervention period of 12 months and based on unit prices for the reference year (2012). If needed, prices were indexed to the reference year using a consumer price index of 1.02 per year (Hakkaart-van Roijen, Tan, and Bouwmans 2011).
Health-Associated Main Outcome Measurements
For the cost-utility analysis, the outcome was health-related quality of life expressed as quality-adjusted life years (QALYs). QALYs were calculated by multiplying the utility score of a state of health, assessed by means of the EuroQol (EQ-5D-3L) (Brooks 1996) , by the amount of time an older adult spent in that particular state of health. Linear interpolation was used for transitions between states of health. For those who died during the intervention period, we multiplied baseline utility scores by total survival time. Dutch tariffs were used to estimate the utility score (0-1) for each participating older adult (Lamers et al. 2005) .
For the cost-effectiveness analyses, the first outcome was the number of days an older adult was "able to age in place," that is, to have no long-term stay in a nursing home. Data on these stays were obtained from the long-term care administration office. Number of days "able to age in place" was then computed as 365 days-number of days in a nursing home. Second outcome for the cost-effectiveness analysis was the proportion of older adults, whose risk profile remained "Robust" or was improved at 12-month follow-up. The latter involved being assigned a profile with a lower risk.
Statistical Analysis
First, we assessed baseline characteristics, overall, and per risk profile. Next, differences in main outcomes between Embrace and care-as-usual groups were assessed using t-statistics for the QALYs, and "days able to age in place" and logistic regression for the binary outcome "risk profile improvement." Costs were presented as arithmetic means, and differences between groups were compared using t-test and nonparametric bootstraps (Thompson and Barber 2000) . To assess consistency and homogeneity of the effect over all Elderly Care Teams and to account for potential skewness, we used multilevel analyses with older adults as lower level and GP practices as higher level, adjusted for age, gender, and baseline values. In addition, we calculated the differences in costs within conditions during the year before the intervention and during the 1-year intervention period, and applied multilevel analyses to assess differences in change between conditions. Missing items regarding patient-reported outcomes, costs, and informal care hours were assumed to be missing at random and imputed at item level by multiple imputation using Bayesian techniques (van Buuren 2007), generating 20 imputed datasets. We used condition, risk profile, GP, sex, marital status, living situation, educational level, income, available data on health care and social care cost, and receipt of help with filling in the questionnaire as covariates of the missing predictor models. Measurement instrument scale scores of patientreported outcomes, which were missing due to loss to follow-up, were imputed by the mean change of deterioration of completed cases, since we assumed that older adults deteriorate over time (Eklund and Wilhelmson 2009) .
Incremental cost-effectiveness ratios (ICERs) were calculated for all outcomes by dividing the difference in costs between the intervention and careas-usual groups by the difference in effectiveness between both. For the bootstrap simulations, we randomly resampled cost-effectiveness pairs from the imputed trial datasets, equally many as the number of participants per group. We calculated averages of outcomes and costs per bootstrap simulation. Given the structure of the dataset, being an imputed dataset, we replicated these calculations 10,000 times to estimate uncertainty intervals (Briggs, Wonderling, and Mooney 1997) . Results of the bootstraps are presented in cost-effectiveness planes and cost-effectiveness acceptability curves (CEACs) (Briggs and Fenn 1998) . Cost-effectiveness planes show differences in costs on the vertical axis and differences in effect on the horizontal axis. For example, bootstrapped cost-effectiveness pairs located in the southeast quadrant show Embrace to be more effective and less costly than care-as-usual. Then again, the preference for an intervention depends on the threshold value, that is, what society is willing to pay for an effectiveness gain. The CEACs show the probability that the intervention is cost effective in comparison with care-asusual for a range of ceiling ratios, which are defined as willingness to pay to gain one unit of effect (Fenwick and Byford 2005) .
Although a formal threshold for willingness to pay has not been defined within the Netherlands, a ceiling ratio between EUR 20,000 and EUR 80,000 for a QALY gained is most often assumed (Boersma, Broere, and Postma 2010) . Regarding an additional "day able to age in place" and a percentage point of "risk profile improvement," no thresholds are available, as these outcomes have never been used in a cost-effectiveness analysis before. Nevertheless, as an approximation, we used EUR 200 to EUR 250, the cost of a day in a nursing home (Hakkaart-van Roijen, Tan, and Bouwmans 2011; United States Department of Health & Human Services 2015), as it is most likely that a societal willingness to pay for a "day able to age in place" would be of that order of magnitude. For percent of "risk profile improvement," we presented the probability of the intervention being cost effective for a range of ceiling ratios: EUR 0 to EUR 10,000. Peters et al. (2015) found that a point increase in "frailty" or "complexity of care needs"-instruments we used for assignment to risk profiles-was associated with a 15 percent or 6 percent increase in cost the next year, respectively.
Finally, we performed sensitivity analyses. We performed CEA and cost-utility analysis using complete cases only. Cases were considered complete if data on medical costs were available from the registries and an older adult had completed the 12-month intervention period. All analyses were performed on the level of the total sample and per risk profile. We used SPSS/ PASW 23 (IBM Corp. Released 2015. IBM SPSS Statistics for Windows. IBM Corp., Armonk, NY) for statistical analysis. For bootstrapping, we used Microsoft Excel 2010. Figure 1 shows the flow of older adults through the study, and in Table 1 , the baseline characteristics are presented. Of the 1,456 older adults who started the intervention, 1,131 (78 percent) completed it. Most older adults were lost to the researcher's data acquisition (see Figure 1 ). Loss to follow-up and number of older adults with missing data on medical care costs, and older adults who were lost to follow-up and had also missing data on medical care costs, were similar for the intervention and control groups, overall, and per risk profile. Older adults lost to follow-up were significantly (p < .01) older, more frail, had a greater complexity of care needs, had a lower health-related quality of life, and had higher costs during the intervention period than other older adults who completed the 12-month intervention period. Furthermore, some statically significant differences were found between older adults with incomplete data versus older adults with complete data, and between older adults that completed the intervention period and had complete data, versus those that did not (see Table S2 ).
RESULTS

Participant and Baseline Characteristics
Care and Support Costs
In Table 2 health care utilization in the year before the intervention period (baseline), the mean costs per participating older adult during the 1-year intervention period, and the difference between these years are presented. We found baseline total health care utilization within the Embrace groups to be higher than care as usual (EUR 9203 vs. EUR 8346), although differences were not statically significant, with the exception for informal care within the Robust profile.
Mean total costs during the 1-year intervention period (including intervention costs) were significantly higher for older adults in the Embrace group, compared to older adults in the care-as-usual group (EUR 13,073 including EUR 684 intervention costs vs. EUR 10,677, MD: 2397, CI: 547; 427, p = .01). For the risk profiles separately, the mean total costs during the 1-year intervention period did not differ significantly between conditions. Regarding subsets, costs of "informal care" in the risk profile "Robust" were statistically significantly higher for the intervention group (EUR 526 vs. EUR 195, MD: 331, CI: 61;600, p = .02).
Finally, increase or decrease in costs in the 1-year intervention period compared with the year before intervention did not differ with statistical significance between conditions. For the risk profiles separately, the total costs (including intervention cost) differed significantly between conditions within the risk profile 'Frail' (EUR 6465 vs. EUR 1887, MD: 4629, CI: 898;8359, p = .02). Same trends were found in MDS-e data (not presented), and no differences were found between GP practices. 
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Effects on Health-associated Main Outcomes
Differences between conditions were small for all health-associated outcomes (see Table 3 ) and were consistent and homogeneous over all Elderly Care Teams. Differences in QALYs ranged from 0.00 for the risk profile "Frail" to a maximum of 0.02 for the risk profile "Robust" with small confidence intervals ranging from À0.01 to 0.05. Differences in days "able to age in place" were small as well: 358 in the Embrace group and 357 in the control group (MD: 0.84, CI: À3.76;5.46). The proportion of older adults in the total sample, whose risk profile remained stable or improved, was 61.3 percent for the intervention group and 60.2 percent for the control group (MD: 1.17, CI: À3.86;6.18). Details on changes between the risk profiles at baseline and follow-up are presented in Table S3 .
Cost-utility Analyses
Overall, the ICER was EUR 188,975 for an additional QALY gained in the intervention group. Of the bootstrapped cost-effect pairs, 86 percent were located in the northeast quadrant, indicating that Embrace was more effective and more expensive than care-as-usual (see Table 3 and Figure 2 ). The CEACs indicated that, for a willingness to pay EUR 20,000 for a QALY gained, the probability that Embrace is cost effective was 1 percent. For a willingness to pay EUR 80,000, the probability was 14 percent. Comparable results were found for the three risk profiles (see Table 3 and Figure 2 ).
Cost-effectiveness Analyses
Cost-effectiveness analyses showed that the ICER for the total sample was EUR 2857 for an additional day to age in place (see Table 3 ). For the risk profile "Complex care needs," the ICER was EUR 766 and, for the risk profiles "Robust" and "Frail," Embrace was less effective and more costly, and therefore inferior to care-as-usual. The CEACs (see Figure 2 ) indicated that the probability that Embrace is cost effective were <80 percent for a willingness to pay EUR 250 for an additional "day able to age in place." Concerning "risk profile improvement or stabilization," the ICER for the total sample was EUR 2055. For the risk profiles "Complex care needs" and "Frail," these ICERs were EUR 1042 and EUR 2044, respectively. For the risk profile "Robust," Embrace was inferior to care-as-usual. Within the risk profile "Complex care needs," the probability that Embrace would be cost Risk decreased refers to the risk profiles "complex"
and "frail"; risk remained stable refers to risk profile "robust.
effective was ≥80 percent in case of a willingness to pay EUR 10,000 for an additional percentage point of "risk profile improvement" (see Figure 2 ).
Sensitivity Analyses
Of the 1456 older adults, we included 904 (62 percent) older adults in the complete case analysis. The results showed that differences in total costs decreased, while differences in outcomes between conditions remained small (see Table S4 ). In contrast to the ITT analysis, the probability that Embrace is cost effective was <80 percent at a willingness to pay 10,000 for a percentage point of "risk profile improvement" for the risk profile "Complex care needs." Furthermore, the probability that Embrace would be cost effective was >80 percent at a willingness to pay EUR 250 for an additional "day to age in place" within the risk profile "Complex care needs" (see Figure S1 ).
DISCUSSION
Our study results show that, within a time horizon of 12 months, Embrace, a comprehensive person-centered integrated care service for older adults living in the community, was not cost effective. Embrace might be considered worthwhile in terms of "risk profile improvements" for older adults with "Complex care needs," if society is willing to invest substantially. Our finding of a lack of overall advantages for Embrace might be explained in several ways. First, the EQ-5D as used might have been too insensitive vis-a-vis the benefits of the intervention. Although the EQ-5D is widely used as a measurement of health status, it focuses primarily on physical functioning; integrated care services, however, target psychological functioning, and social well-being as well (van Leeuwen et al. 2015b; Makai et al. 2015) . Second, the proactive approach by the Elderly Care Team may have increased the awareness of a need of care leading to more use of services and informal care early in the care trajectory, and thus leading to higher costs in the intervention groups. In similar studies, it was found that this "investment" may need more time than 12 months to have an effect on patient outcomes (Toseland et al. 1997; Boult et al. 2011; You et al. 2012) . We found that Embrace improved quality of care (Uittenbroek et al. 2017) . Results of a qualitative study indicated that Embrace reinforced the participants' ability to stay in control, and feel safe and secured, in contrast to the experienced fears, decreasing social contacts, and loss of control before Embrace (Spoorenberg et al. 2015b) . These outcomes could potentially be an indication of positive outcomes in the longer run. Third, Embrace might not have been sufficiently integrated into the health care system to have effects on service use and costs. Older adults also use a wide range of services outside the domain of the integrated care as offered, such as hospital and paramedical care. These services were not included in Embrace and may have diluted the contrast between intervention and control groups. Finally, although not statically significant, differences in utilization between both groups were already present at baseline to the detriment of the intervention group, despite Person-Centered Care for Older Adultsthe randomization with balanced allocation. However, adjustment for these differences at baseline did not show differences in costs between conditions, with the exception of the risk profile "Frail" in which total costs (intervention costs included) differed between conditions. We introduced two new outcomes so as to be able to capture the specific effects of integrated care and found that Embrace could be cost effective in terms of "risk profile improvements" for older adults with "Complex care needs." However, one should proceed cautiously, as society's willingness to pay for these novel outcomes has not yet been established (Gafni and Birch 2006) . Given the dissimilarities in average costs between risk profiles, one percentage point of "risk profile improvement" might be equivalent to a EUR 10,000 cost reduction in the following year. For willingness to pay for a "day able to age in place," we suggested a threshold based on residential care costs. However, we might have double counted the benefit of the intervention, as we included a nursing home day as both numerator and denominator in the incremental cost-effectiveness ratio. Nevertheless, the additional gain from not having to stay in a nursing home might be valued even higher than the reallocation of costs, and it may also have nonfinancial benefits, such as increased dignity, independence, social contacts, and even physical health. (Wiles et al. 2012; Young et al. 2015) . Further research on society's willingness to pay for these outcomes is needed.
The lack of effects found in our study-and in other recent studies (van Leeuwen et al. 2015a; Makai et al. 2015; Metzelthin et al. 2015; Blom et al. 2016 )-may also indicate that new payment models and accountability agreements are essential to overcome fragmentation in health care provision and financing (Enthoven 2009; Schneider, Hussey, and Schnyer 2011; Song et al. 2014 ). An example of a cost-effective integrated care service for older adults is the "Program of All-inclusive Care for the Elderly (PACE)" (Eng et al. 1997 ). This service is provided to nursing home-eligible older adults with the aim of maximizing their autonomy and continued residence in the community, in addition to providing quality care at a lower cost. It is provided by highly integrated and accountable care organizations and leads to both improved health outcomes and reduced costs (Hirth, Baskins, and Dever-Bumba 2009; Wieland et al. 2010; Meret-Hanke 2011) . Unlike Embrace, however, this service focuses on older adults already in need of care. When targeting all older adults living in the community, revolutionary changes in health care and in long-term and social care payment models will be needed (Humphries 2015) .
Strengths of this study are its design, that is, a randomized controlled trial with balanced allocation (Zielhuis et al. 1990) , in addition to a large community-based sample. Moreover, we used health care registries as primary data sources, resulting in highly reliable data that are also used for financial reimbursement (Smeets, de Wit, and Hoes 2011) . Some (potential) limitations need to be addressed as well. We randomized participating older adults within the GP practices, which may have caused some contamination of the control group and thus an underestimation of the advantages of Embrace. We found no significant differences between conditions in the intention to treat and complete case analysis. However, the differences between older adults lost to follow-up and older adults who completed the 12-month intervention period might indicate that there is a selective dropout and generalization of our findings requires further investigation. Furthermore, we were not able to retrieve data from all health insurers. This is unlikely to have caused bias, as rates of older adults without complete data on costs did not differ vis-a-vis conditions, although this incompleteness might have reduced accuracy. In addition, we found comparable trends in data that were based on insurance data and self-report questionnaires (MDS-e) between groups and profiles. Finally, for the complete case analyses, we included participants who completed the 12-month intervention period and had complete data on medical care cost. This restriction of the subsample may have affected our findings.
In conclusion, our study shows that it is feasible to provide care and support that correlates with intensity levels that depend on risk profiles. According to current standards, Embrace is not considered cost effective; however, it might be considered worthwhile in terms of "risk profile improvements" for those older adults with "Complex care needs." Given the short time horizon of the study, the effects may be shown to increase in the longer run (Toseland et al. 1997) . Other results regarding Embrace, such as improved quality of care and reinforced ability of the participant to stay in control, may lead to more positive outcomes in a longer follow-up. Research on its long-term costeffectiveness is therefore recommended. Furthermore, our findings need confirmation in other populations of community-living elderly. Much can be gained in that regard not only in terms of costs but also most importantly in terms of health, well-being, and quality of care.
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